Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 19 Apr 2024

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

in Thoracic Oncology

Siyuan Huang
Linlin Li
Ningning Yan
Huixian Zhang
Qianqian Guo
Sanxing Guo
Di Geng
Xincheng Liu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331387

1,558 views
3 citations

Editorial

Published on 19 Apr 2024

Editorial: Updates on combination therapy for lung cancer volume II

in Thoracic Oncology

Alberto Pavan
Liyun Shi
Muhammad Abbas

Frontiers in Oncology

doi 10.3389/fonc.2024.1393278

752 views

Original Research

Published on 18 Apr 2024

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors

in Thoracic Oncology

Balazs Halmos
Pragya Rai
Jae Min
Xiaohan Hu
Diana Chirovsky
Mark Shamoun
Bin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1285280

2,097 views
2 citations

Case Report

Published on 18 Apr 2024

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

in Thoracic Oncology

Dan Li
Yue Zhu
Jincheng Song
Dafu Yang
Saiqiong Cui
Xin Liu
Le Wang
Jiangyan Zhang
Evenki Pan
Zhaoxia Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1339511

1,577 views

Systematic Review

Published on 17 Apr 2024

Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis

in Thoracic Oncology

Yuxuan Cao
Xinbo Liu
Jiayi Liu
Ziyi Su
Wenxuan Liu
Lei Yang
Liwen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1357248

1,879 views

Case Report

Published on 16 Apr 2024

Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion

in Thoracic Oncology

Su-Su Dong
Wen Dong
Ya-Fen Tan
Qiang Xiao
Tian-Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1370901

1,306 views

Systematic Review

Published on 16 Apr 2024

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

in Thoracic Oncology

Wen Zhong
Xiaofei Zhao
Xiabiao Zhang
Yiwen Xu
Mengqian Liu
Xiaoyun Yang
Yi Jiang
Xiaozhu Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1358101

3,384 views
1 citation

Case Report

Published on 15 Apr 2024

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

in Thoracic Oncology

Eleonora Faccioli
Federica Grosso
Andrea Dell’Amore
Sara Delfanti
Giovanni Zambello
Luigi Cerbone
Gianluca Canu
Antonina De Angelis
Viola Sambataro
Federica Pezzuto

Frontiers in Oncology

doi 10.3389/fonc.2024.1378530

1,176 views
1 citation

Original Research

Published on 12 Apr 2024

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma

in Thoracic Oncology

Ye Wang
Yingqiu Song
Runze Wang
Yu Wu
Mo Li
Ke Xu
Rong He
Zheng Wang
Qingqing Li
Feng-Ming (Spring) Kong

Frontiers in Oncology

doi 10.3389/fonc.2024.1265228

1,509 views
1 citation

Original Research

Published on 10 Apr 2024

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

in Thoracic Oncology

Thomas Jordan
Thitikorn Nuamek
Isabella Fornacon-Wood
Raffaele Califano
Joanna Coote
Margaret Harris
Hitesh Mistry
Paul Taylor
David Woolf
Corinne Faivre-Finn

Frontiers in Oncology

doi 10.3389/fonc.2024.1328871

1,679 views
3 citations

Brief Research Report

Published on 10 Apr 2024

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

in Thoracic Oncology

Eziafa I. Oduah
Susan T. Sharfstein
Nagashree Seetharamu
Steven R. Grossman
Larisa Litovchick

Frontiers in Oncology

doi 10.3389/fonc.2024.1363543

1,369 views
1 citation

Case Report

Published on 09 Apr 2024

A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review

in Thoracic Oncology

Jian Guo
XiaoHui Lv
Wei Zhang
Fang Dong
Lei Li
Juan Liu
Bing Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1359985

1,020 views

Original Research

Published on 08 Apr 2024

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

in Thoracic Oncology

Song Hu
Hao Ming
Qian He
Ming Ding
Hao Ding
Chong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1314301

2,100 views
2 citations

Correction

Published on 08 Apr 2024

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

in Thoracic Oncology

Reem Altaf
Umair Ilyas
Anmei Ma
Meiqi Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1377858

599 views

Original Research

Published on 08 Apr 2024

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial

in Thoracic Oncology

Da Zhao
Zhengguo Li
Xinli Hou
Lei Yang
Zeng Li
Li Yan
Hongling Li
Hua Liu
Xiaoping Liu
Feixue Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1335009

1,271 views

Case Report

Published on 04 Apr 2024

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

in Thoracic Oncology

Changhong Dong
Chenxi Hu
Yanting Jiang
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1368059

1,224 views
1 citation